Cargando…
Technetium-99m MDP bone scintigraphic findings of hypercalcemia in accelerated phase of chronic myelogenous leukemia.
Hypercalcemia in accelerated phase of chronic myelogenous leukemia (CML) is very rare. Its pathogenesis is considered humoral hypercalcemia of malignancies mediated by parathyroid hormone-related protein (PTHrP). In severe hypercalcemia, calcifications in kidneys, skin, vessels, heart, and stomach m...
Autores principales: | Kwak, H. S., Sohn, M. H., Lim, S. T., Kwak, J. Y., Yim, C. Y. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054685/ https://www.ncbi.nlm.nih.gov/pubmed/11069001 |
Ejemplares similares
-
Diagnosis of bone infection by complementary role of technetium-99m MDP and technetium-99m hexamethylpropylene-amineoxime-leukocytes
por: Al-Zahrani, Abdullah, et al.
Publicado: (2012) -
Poor renal uptake of technetium-99m-DMSA and technetium-99m-MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
por: Kim, S. E., et al.
Publicado: (1994) -
Extraosseous Accumulation of Technetium-99m-Methyl Diphosphonate ((99m)Tc-MDP) in a Child with ALL: A Case Report
por: Banezhad, Farnaz, et al.
Publicado: (2018) -
PSAT218 Technetium 99m-Methyl Diphosphonate (99mTc MDP) Radioguided Surgery in Patient With Tumor-Induced Osteomalacia (TIO)
por: Khan, Sara A, et al.
Publicado: (2022) -
Marked gastric uptake of Tc-99m methylene diphosphonate (MDP) in a patient with myeloma and hypercalcemia
por: Foley, Kieran, et al.
Publicado: (2015)